This website uses cookies to enhance the user experience.
A

AGIANA PHARMACEUTICALS AS927 648 946

Research
Limited company
Gaustadalléen 21 0349 OSLO, Norge

AGIANA PHARMACEUTICALS AS

Keywords

researchdevelopment worknatural sciencesengineeringtechnologymedicineagricultureinterdisciplinary research

Organization

Chairman of the board
Years since formation
4 years
since Sep 3, 2021
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
36,050
1 share class
Total number of shareholders
4
1 company, 3 persons

Financials

Total operating income 2023
235,252
NOK
Annual total result 2023
-2,946,196
NOK
Total equity 2023
-5,875,129
NOK
Last update: Aug 29, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Board Member-
Board Member-

Others

NameRoleShares
D
DYNAMIK SMART ACCOUNTING AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
8.32 %
directly
-
5.55 %
directly
Last update: Oct 14, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
Ordinary shares
17,686
49.06 %
I
INVEN2 AS
Ordinary shares
13,364
37.07 %
Ordinary shares
3,000
8.32 %
Ordinary shares
2,000
5.55 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year202320222021
Total operating income
235,252
0
0
Annual Total Result
-2,946,196
-2,958,933
0
Total assets
1,680,930
4,226,158
30,000
Total liabilities
7,556,059
7,155,091
0
Total equity
-5,875,129
-2,928,933
30,000

P&L

Year202320222021
Total operating income
235,252
0
0
Total operating costs
2,870,809
2,845,924
0
Operating result
-2,635,557
-2,845,924
0
Financial income/costs
-310,640
-113,009
0
Profit before tax
-2,946,196
-2,958,933
0
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-2,946,196
-2,958,933
0

Balance overview

Year202320222021
Total fixed assets
0
0
0
Total current assets
1,680,930
4,226,158
30,000
Total assets
1,680,930
4,226,158
30,000
Short term debt
466,059
429,535
0
Long term debt
7,090,000
6,725,556
0
Total liabilities
7,556,059
7,155,091
0
Contributed capital
30,000
30,000
30,000
Retained earnings
-5,905,129
-2,958,933
0
Total equity
-5,875,129
-2,928,933
30,000
Total equity and liabilities
1,680,930
4,226,158
30,000

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
1120
Public incorporated enterprises, owned by central government
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.19
Industrial group
Other research and experimental development on natural sciences and engineering
72.190
Industrial group
Other research and experimental development on natural sciences and engineering